Delivery Order SPE2DB22D9247-SPE2DB25FS2FR

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $1,946.41 firm fixed-price delivery order is for the purchase of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a brand-name insulin product, with a period of performance extending through March 19, 2024. The award is made against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 under the DLA's...
This federal contract award, valued at $8,238.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Lantus Solostar 100 unit/mL 3mL, a prescription medication used to treat diabetes. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under contract SPE2DB22D9206 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $2,639.20 firm fixed-price order is for the pharmaceutical product LANTUS SOLOSTAR 100 UNIT/ML 3ML. The delivery order has a completion date of March 19, 2024. DMS Pharmaceutical Group holds an indefinite delivery vehicle (IDV) contract SPE2DB24FV5CT with DLA valued up to $4,999,999 through 2025,...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,336.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a specialized medication, with a period of performance ending on December 10, 2024. This award is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,441.26 contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a prescription insulin product. This delivery order is part of a larger indefinite delivery contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with the Defense Logistics Agency to provide a broad...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,098.40 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a prescription medication used for the treatment of diabetes. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical in Park Ridge, Illinois. The contract was awarded on February 6, 2024 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract has a completion date of February 7, 2024 and a potential value of $2,441.26 under a firm fixed-price delivery order. DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $2,441.26 order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin product. The delivery order was issued under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract SPE2DB with DLA, which enables the agency to place orders for a broad range of pharmaceutical...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, SPE2DX15D9249|SPE2DX24FTMGE, valued at $1,319.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens and is not set aside for any specific business category. DMS Pharmaceutical Group holds a larger indefinite delivery contract, 4600082013 under the...
The U.S. Defense Logistics Agency has awarded a $9,897.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. DMS Pharmaceutical Group will provide Lantus SoloStar 100 Unit/mL 3mL syringes to the agency. This delivery order is issued against DMS Pharmaceutical Group's existing indefinite delivery contract, SPE2DB, with a potential value of up to $4,999,999 to supply a broad range of pharmaceutical products to military...
  • SPE2DB22D9247
    Indefinite Delivery Contract
  • SPE2DB22D9247-SPE2DB25FS2FR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,043.48 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, with a completion date of May 22, 2025.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.

Generated 8/20/25, 9:54 AM